BR100 Increased By (0.39%)
BR30 Increased By (0.47%)
KSE100 Increased By (0.99%)
KSE30 Increased By (1.19%)
AGHA 6.50 Increased By ▲ 0.18 (2.85%)
BECO 4.40 Increased By ▲ 0.13 (3.04%)
BML 62.45 No Change ▼ 0.00 (0%)
BOP 31.39 Increased By ▲ 0.16 (0.51%)
CNERGY 11.81 Increased By ▲ 0.22 (1.9%)
CSIL 5.95 Increased By ▲ 0.23 (4.02%)
FCCL 61.30 Decreased By ▼ -0.24 (-0.39%)
FFL 14.88 Decreased By ▼ -0.14 (-0.93%)
FNEL 1.24 Increased By ▲ 0.01 (0.81%)
KEL 6.29 Increased By ▲ 0.03 (0.48%)
KOSM 6.00 Increased By ▲ 0.44 (7.91%)
LOTCHEM 24.85 Increased By ▲ 0.17 (0.69%)
MLCF 104.13 Increased By ▲ 0.05 (0.05%)
NBP 174.66 Decreased By ▼ -0.62 (-0.35%)
NCPL 52.83 Increased By ▲ 0.06 (0.11%)
NPL 54.48 Increased By ▲ 0.36 (0.67%)
OGDC 315.35 Increased By ▲ 1.96 (0.63%)
PACE 9.41 Increased By ▲ 0.21 (2.28%)
PAEL 35.62 Decreased By ▼ -0.18 (-0.5%)
PIBTL 13.71 Increased By ▲ 0.24 (1.78%)
PPL 223.38 Increased By ▲ 1.57 (0.71%)
PRL 80.79 Increased By ▲ 1.71 (2.16%)
PTC 47.15 Increased By ▲ 0.30 (0.64%)
SSGC 24.15 Increased By ▲ 0.28 (1.17%)
TBL 9.25 Decreased By ▼ -0.06 (-0.64%)
TELE 7.53 Increased By ▲ 0.14 (1.89%)
TPL 24.89 Decreased By ▼ -0.22 (-0.88%)
TPLP 12.88 Increased By ▲ 0.37 (2.96%)
TREET 26.10 Decreased By ▼ -0.15 (-0.57%)
TRG 53.75 Increased By ▲ 0.31 (0.58%)
World

Key facets of the $900 billion U.S coronavirus relief bill

  • On Sunday, bipartisan lawmakers in the United States Congress released a long-awaited $900 billion coronavirus relief bill, which is expected to be signed into law by President Trump.
  • This relief package will be combined with an additional $1.4 trillion in federal funding and tax provisions to facilitate federal agencies through the end of September.
Published Updated

On Sunday, bipartisan lawmakers in the United States Congress released a long-awaited $900 billion coronavirus relief bill, which is expected to be signed into law by President Trump.

This relief package will be combined with an additional $1.4 trillion in federal funding and tax provisions to facilitate federal agencies through the end of September.

Democrats have argued that more relief legislation will be required once President-elect Biden takes office in January, which would include local provisions at the state level; as the United States Congress will have appropriated nearly $4 trillion in federal funding to respond to the coronavirus pandemic, which has claimed the lives of over 300,000 people across the country.

The key facets of this $900 billion relief package are as follows:

  • Stimulus Checks: This bill includes a second-round of direct payments to Americans, with up to $600 for every adult and child. It can be observed that this is half the $1200 disbursements under the CARES Act in March.
  • Unemployment Benefits: This bill will renew two expiring CARES Act programs for an additional 11 weeks, namely the Pandemic Unemployment Assistance which made benefits available to self-employed workers, and the Pandemic Emergency Unemployment Compensation which provided additional weeks of benefits. Furthermore, this bill will include an additional $300 to all weekly unemployment benefits and an additional $100 weekly for those who rely on multiple jobs.
  • Support for Small Businesses: The Paycheck Protection Program, which provided distressed small businesses with forgivable loans to keep them afloat, was granted an additional $284 billion in funds.
  • Housing Assistance: The bill extends the eviction moratorium that is set to expire at the end of the year through the end of January, including $25 billion for rental assistance to families facing eviction.
  • Education: The bill includes several provisions pertaining to elementary, secondary and higher education; providing $82 billion worth of funds for schools and colleges to help them reopen classrooms and prevent virus transmission.
  • Testing: The bill includes $20 billion for the purchase of vaccines, $8 billion for vaccine distribution, $20 billion for states to conduct testing and an additional $20 billion in federal relief for health-care providers.

Comments

Comments are closed for this article.